Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva plus Avastin vs Chemotherapy plus Avastin in advanced NSCLC
NCT00531960Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Roche. Started Jan 2008; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00531960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531960.